173 related articles for article (PubMed ID: 36892036)
21. Downregulated miR-29c correlates with increased BACE1 expression in sporadic Alzheimer's disease.
Lei X; Lei L; Zhang Z; Zhang Z; Cheng Y
Int J Clin Exp Pathol; 2015; 8(2):1565-74. PubMed ID: 25973041
[TBL] [Abstract][Full Text] [Related]
22. Protective effects of BACE1 inhibitory ligand molecules against amyloid beta-induced synaptic and mitochondrial toxicities in Alzheimer's disease.
Pradeepkiran JA; Reddy AP; Yin X; Manczak M; Reddy PH
Hum Mol Genet; 2020 Jan; 29(1):49-69. PubMed ID: 31595293
[TBL] [Abstract][Full Text] [Related]
23. Functional activity of the novel Alzheimer's amyloid β-peptide interacting domain (AβID) in the APP and BACE1 promoter sequences and implications in activating apoptotic genes and in amyloidogenesis.
Bailey JA; Maloney B; Ge YW; Lahiri DK
Gene; 2011 Nov; 488(1-2):13-22. PubMed ID: 21708232
[TBL] [Abstract][Full Text] [Related]
24. Glimepiride attenuates Aβ production via suppressing BACE1 activity in cortical neurons.
Liu F; Wang Y; Yan M; Zhang L; Pang T; Liao H
Neurosci Lett; 2013 Dec; 557 Pt B():90-4. PubMed ID: 24184877
[TBL] [Abstract][Full Text] [Related]
25. BACE1: the beta-secretase enzyme in Alzheimer's disease.
Vassar R
J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-132-3p alleviates neuron apoptosis and impairments of learning and memory abilities in Alzheimer's disease by downregulation of HNRNPU stabilized BACE1.
Qu J; Xiong X; Hujie G; Ren J; Yan L; Ma L
Cell Cycle; 2021 Nov; 20(21):2309-2320. PubMed ID: 34585626
[TBL] [Abstract][Full Text] [Related]
27. Salvianolic Acid B Inhibits Aβ Generation by Modulating BACE1 Activity in SH-SY5Y-APPsw Cells.
Tang Y; Huang D; Zhang MH; Zhang WS; Tang YX; Shi ZX; Deng L; Zhou DH; Lu XY
Nutrients; 2016 Jun; 8(6):. PubMed ID: 27258307
[TBL] [Abstract][Full Text] [Related]
28. Tolfenamic acid downregulates BACE1 and protects against lead-induced upregulation of Alzheimer's disease related biomarkers.
Adwan L; Subaiea GM; Zawia NH
Neuropharmacology; 2014 Apr; 79():596-602. PubMed ID: 24462621
[TBL] [Abstract][Full Text] [Related]
29. Alzheimer's β-secretase (BACE1) regulates the cAMP/PKA/CREB pathway independently of β-amyloid.
Chen Y; Huang X; Zhang YW; Rockenstein E; Bu G; Golde TE; Masliah E; Xu H
J Neurosci; 2012 Aug; 32(33):11390-5. PubMed ID: 22895721
[TBL] [Abstract][Full Text] [Related]
30. Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease.
Chen CH; Zhou W; Liu S; Deng Y; Cai F; Tone M; Tone Y; Tong Y; Song W
Int J Neuropsychopharmacol; 2012 Feb; 15(1):77-90. PubMed ID: 21329555
[TBL] [Abstract][Full Text] [Related]
31. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
[TBL] [Abstract][Full Text] [Related]
32. Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling.
Cho HJ; Jin SM; Youn HD; Huh K; Mook-Jung I
Aging Cell; 2008 Mar; 7(2):137-47. PubMed ID: 18081741
[TBL] [Abstract][Full Text] [Related]
33. Galangin-induced down-regulation of BACE1 by epigenetic mechanisms in SH-SY5Y cells.
Zeng H; Huang P; Wang X; Wu J; Wu M; Huang J
Neuroscience; 2015 May; 294():172-81. PubMed ID: 25779965
[TBL] [Abstract][Full Text] [Related]
34. BACE1 Overexpression Reduces SH-SY5Y Cell Viability Through a Mechanism Distinct from Amyloid-β Peptide Accumulation: Beta Prime-Mediated Competitive Depletion of sAβPPα.
Owens L; Bracewell J; Benedetto A; Dawson N; Gaffney C; Parkin E
J Alzheimers Dis; 2022; 86(3):1201-1220. PubMed ID: 35180123
[TBL] [Abstract][Full Text] [Related]
35. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.
Tian J; Shi J; Zhang L; Yin J; Hu Q; Xu Y; Sheng S; Wang P; Ren Y; Wang R; Wang Y
Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846
[TBL] [Abstract][Full Text] [Related]
36. BACE1 RNA interference improves spatial memory and attenuates Aβ burden in a streptozotocin-induced tau hyperphosphorylated rat model.
Yu CJ; Liu W; Chen HY; Wang L; Zhang ZR
Cell Biochem Funct; 2014 Oct; 32(7):590-6. PubMed ID: 25230339
[TBL] [Abstract][Full Text] [Related]
37. BACE1 in Alzheimer's disease.
Sathya M; Premkumar P; Karthick C; Moorthi P; Jayachandran KS; Anusuyadevi M
Clin Chim Acta; 2012 Dec; 414():171-8. PubMed ID: 22926063
[TBL] [Abstract][Full Text] [Related]
38. Identification of a BACE1 Binding Peptide Candidate for the Prevention of Amyloid Beta in Alzheimer's Disease.
Read J; Suphioglu C
Cell Physiol Biochem; 2019; 53(2):413-428. PubMed ID: 31415717
[TBL] [Abstract][Full Text] [Related]
39. Tenuigenin treatment decreases secretion of the Alzheimer's disease amyloid beta-protein in cultured cells.
Jia H; Jiang Y; Ruan Y; Zhang Y; Ma X; Zhang J; Beyreuther K; Tu P; Zhang D
Neurosci Lett; 2004 Aug; 367(1):123-8. PubMed ID: 15308312
[TBL] [Abstract][Full Text] [Related]
40. The beta-secretase, BACE: a prime drug target for Alzheimer's disease.
Vassar R
J Mol Neurosci; 2001 Oct; 17(2):157-70. PubMed ID: 11816789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
